RxDoctor Payments Data

Gina Duel, PA

Physician Assistant · Aliso Viejo, CANPI 1912985979

Payments from drug & device makers

$11,386in general payments, 2019–2025

Across 603 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Teva Pharmaceuticals USA, Inc.$985
  • AstraZeneca$614
  • Neurocrine Biosciences, Inc.$570
  • Upsher-smith Laboratories LLC$386
  • Merz Pharmaceuticals, LLC$378
  • plus $6K from 50 others

What the payments were for

  • Speaking & faculty fees$651%
  • Food & beverage$11,32199%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)129$2,578
Teva Pharmaceuticals USA, Inc.68$985
AstraZeneca29$614
Neurocrine Biosciences, Inc.35$570
Upsher-smith Laboratories LLC24$386
Merz Pharmaceuticals, LLC14$378
Lilly USA, LLC19$301
Jazz Pharmaceuticals Inc.18$295
SK Life Science, Inc.13$285
Biohaven Pharmaceuticals, Inc.17$270
Biohaven Pharmaceutical Holding Company Ltd.13$244
Eisai Inc.13$238
Amgen12$234
Sunovion Pharmaceuticals Inc.13$221
Acadia Pharmaceuticals Inc9$220
Amneal Pharmaceuticals LLC13$214
Kyowa Kirin, Inc.8$204
Takeda Pharmaceuticals U.S.A., Inc.11$201
UCB, Inc.10$182
Supernus Pharmaceuticals, Inc.11$178
Alnylam Pharmaceuticals Inc.8$167
CSL Behring11$166
Avanir Pharmaceuticals, Inc.8$153
MDD US Operations, LLC9$142
Si-bone, Inc.1$138
Biogen10$126
Avion Pharmaceuticals7$118
Abbott2$114
Axsome Therapeutics, Inc.5$113
Johnson & Johnson3$108
Globus Medical2$99
Acorda Therapeutics, Inc6$97
Impel Pharmaceuticals Inc.4$95
Lundbeck LLC4$85
Pfizer4$83
Neurelis, Inc.5$80
Almatica Pharma LLC5$73
Arbor Pharmaceuticals, Inc.4$71
Adamas Pharmaceuticals, Inc.3$65
Harmony Biosciences LLC2$58
Tanabe Pharma America, Inc.3$55
Alfasigma USA, Inc.3$54
Medtronic1$53
Averitas Pharma Inc.1$38
Azurity Pharmaceuticals, Inc.2$34
Argenx US, Inc.1$25
Cala Health, Inc.1$24
Bausch Health US, LLC1$24
Otsuka America Pharmaceutical, Inc.1$21
Catalyst Pharmaceuticals, Inc.1$20
Sun Pharmaceutical Industries Inc.1$18
OWP Pharmaceuticals, Inc.1$17
Revance Therapeutics, Inc.1$16
Akcea Therapeutics, Inc.1$16
Idorsia Pharmaceuticals US Inc1$13
Scilex Pharmaceuticals Inc.1$11

How this compares

$11,386 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$36,924
Medicare patients
166
Services billed
322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl19$895
Methylprednisolone28$196
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$141
Oxycodone Hcl23$134
Methocarbamol19$102

Paid to pharmacies, not to this prescriber.

Other physician assistant in Aliso Viejo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →